Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online January 13, 2023.
Article Versions
- You are currently viewing an Earlier version of this article (January 13, 2023 - 12:47).
- earlier version (February 28, 2023 - 10:27).
- View the most recent version of this article
Copyright & Usage
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution CC BY License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Author Information
- Chandrali Bhattacharya1,
- Ann-Sofie Sandinge2,
- Ryan A. Bragg3,
- Maria Heijer4,
- Jingjing Yan5,
- Linda C. Andersson5,
- Ulrik Jurva2,
- Marta Pelay-Gimeno6,
- Wouter H.J. Vaes7,
- Rianne A.F. de Ligt6,
- Malin Gränfors8,
- Carl Amilon9,
- Eva-Lotte Lindstedt10,
- Somasekhara R. Menakuru11,
- Pavlo Garkaviy12,
- Lars Weidolf13, and
- V. Sashi Gopaul14,*
- 1Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, United States
- 2Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Sweden
- 3Early Chemical Development, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, United Kingdom
- 4Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 5DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 6TNO, Netherlands
- 7Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Netherlands
- 8Early Product Development, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 9Formerly of Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca, Sweden
- 10Formerly BioPharmaceuticals R&D, AstraZeneca, Sweden
- 11Quotient Sciences, United Kingdom
- 12Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Sweden
- 13iMed CVMD DMPK, AstraZeneca R&D Molndal, Sweden
- 14Early Research and Development Cardiovascular Renal and Metabolism, AstraZeneca R&D Gothenburg, Sweden
- ↵* Corresponding Author:
V. Sashi Gopaul, Early Research and Development Cardiovascular Renal and Metabolism, AstraZeneca R&D Gothenburg, Pepparedsleden 1, 431 50, Mölndal, Sweden. E-mail: sashi.gopaul{at}astrazeneca.com